Assunto: ENDOCRINOLOGIA PEDIÁTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YU, H et al. A doble blind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficient (GHD) children. 1998, Anais.. New Orleans : Louisiana, 1998: The Endocrinology Society Annual Meeting , 80, 1998. . Acesso em: 17 jul. 2024.APA
Yu, H., Cassorla, F., Tiulpakov, A., Shi, Y. -F., Setian, N., Bercu, B., et al. (1998). A doble blind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficient (GHD) children. In . New Orleans : Louisiana, 1998: The Endocrinology Society Annual Meeting , 80.NLM
Yu H, Cassorla F, Tiulpakov A, Shi Y-F, Setian N, Bercu B, Arango A, Kletter G, Pescovitz O, DiMartino J, Krupa D, Cambria M, Kanojia P, Bach MA. A doble blind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficient (GHD) children. 1998 ;[citado 2024 jul. 17 ]Vancouver
Yu H, Cassorla F, Tiulpakov A, Shi Y-F, Setian N, Bercu B, Arango A, Kletter G, Pescovitz O, DiMartino J, Krupa D, Cambria M, Kanojia P, Bach MA. A doble blind placebo-controlled efficacy trial of an oral growth hormone (GH) secretagogue (MK-0677) in GH deficient (GHD) children. 1998 ;[citado 2024 jul. 17 ]
